{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T21:18:10Z","timestamp":1742937490202,"version":"3.40.3"},"publisher-location":"Cham","reference-count":70,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031598142"},{"type":"electronic","value":"9783031598159"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-59815-9_12","type":"book-chapter","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:55Z","timestamp":1723154515000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monocytic Phagocytes in the Immunopathogenesis of Cytokine Storm Syndromes"],"prefix":"10.1007","author":[{"given":"Pui Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1146\/annurev.immunol.021908.132557","volume":"27","author":"C Auffray","year":"2009","unstructured":"Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669\u201392.","journal-title":"Annu Rev Immunol"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3389\/fimmu.2019.01893","volume":"10","author":"S Gordon","year":"2019","unstructured":"Gordon S, Pluddemann A. The mononuclear phagocytic system. Generation of diversity. Front Immunol. 2019;10:1893.","journal-title":"Front Immunol"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/10409238.2015.1033511","volume":"50","author":"CE Bryant","year":"2015","unstructured":"Bryant CE, et al. Advances in Toll-like receptor biology: modes of activation by diverse stimuli. Crit Rev Biochem Mol Biol. 2015;50:359\u201379.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1002\/art.22981","volume":"56","author":"N Fall","year":"2007","unstructured":"Fall N, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum. 2007;56:3793\u2013804.","journal-title":"Arthritis Rheum"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3899\/jrheum.100655","volume":"38","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol. 2011;38:769\u201374.","journal-title":"J Rheumatol"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham RR, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38:550\u20135.","journal-title":"Nat Genet"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.MCHD-0021-2015","volume":"4","author":"TA Kufer","year":"2016","unstructured":"Kufer TA, Nigro G, Sansonetti PJ. Multifaceted functions of NOD-like receptor proteins in myeloid cells at the intersection of innate and adaptive immunity. Microbiol Spectr. 2016;4:1\u20139.","journal-title":"Microbiol Spectr"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46:1140\u20136.","journal-title":"Nat Genet"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ng.3066","volume":"46","author":"N Romberg","year":"2014","unstructured":"Romberg N, et al. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet. 2014;46:1135\u20139.","journal-title":"Nat Genet"},{"issue":"5","key":"12_CR10","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","volume":"139","author":"SW Canna","year":"2016","unstructured":"Canna SW, et al. Life-threatening NLRC4-associated hyperinflammation successfully treated with Interleukin-18 inhibition. J Allergy Clin Immunol. 2016;139(5):1698\u2013701. https:\/\/doi.org\/10.1016\/j.jaci.2016.10.022.","journal-title":"J Allergy Clin Immunol"},{"key":"12_CR11","volume-title":"2015 ACR\/ARHP annual meeting (San Francisco, CA)","author":"G Prencipe","year":"2015","unstructured":"Prencipe G, Bracaglia C, Gatto A, Pardeo M, Lapeyre G, Raganelli L, Marasco E, Insalaco A, Ferlin W, Nelson R, de Min C, De Benedetti F. Anti interferon-gamma (IFNg) monoclonal antibody treatment in a child with NLRC4-related disease and severe hemophagocytic lymphohistiocytosis (HLH) [abstract]. In: 2015 ACR\/ARHP annual meeting (San Francisco, CA); 2015."},{"issue":"1","key":"12_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","volume":"76","author":"C Bracaglia","year":"2016","unstructured":"Bracaglia C, et al. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2016;76(1):166\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209020.","journal-title":"Ann Rheum Dis"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","volume":"133","author":"H Takada","year":"2003","unstructured":"Takada H, et al. Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis. Clin Exp Immunol. 2003;133:448\u201353.","journal-title":"Clin Exp Immunol"},{"key":"12_CR14","first-page":"459","volume":"63","author":"MH Moradinejad","year":"2011","unstructured":"Moradinejad MH, Ziaee V. The incidence of macrophage activation syndrome in children with rheumatic disorders. Minerva Pediatr. 2011;63:459\u201366.","journal-title":"Minerva Pediatr"},{"key":"12_CR15","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34:1133\u20138.","journal-title":"J Rheumatol"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","volume":"61","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013;61:345\u20138.","journal-title":"Cytokine"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010;49:1645\u201353.","journal-title":"Rheumatology (Oxford)"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clim.2012.11.004","volume":"146","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, et al. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome. Clin Immunol. 2013;146:73\u20136.","journal-title":"Clin Immunol"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","volume":"12","author":"K Tominaga","year":"2000","unstructured":"Tominaga K, et al. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol. 2000;12:151\u201360.","journal-title":"Int Immunol"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","volume":"121","author":"EM Behrens","year":"2011","unstructured":"Behrens EM, et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest. 2011;121:2264\u201377.","journal-title":"J Clin Invest"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/art.37958","volume":"65","author":"SW Canna","year":"2013","unstructured":"Canna SW, et al. Interferon-gamma mediates anemia but is dispensable for fulminant Toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice. Arthritis Rheum. 2013;65:1764\u201375.","journal-title":"Arthritis Rheum"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.1073\/pnas.1524487113","volume":"113","author":"LK Weaver","year":"2016","unstructured":"Weaver LK, Chu N, Behrens EM. TLR9-mediated inflammation drives a Ccr2-independent peripheral monocytosis through enhanced extramedullary monocytopoiesis. Proc Natl Acad Sci U S A. 2016;113:10944\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaut.2019.02.005","volume":"100","author":"S Mahajan","year":"2019","unstructured":"Mahajan S, et al. Plcgamma2\/Tmem178 dependent pathway in myeloid cells modulates the pathogenesis of cytokine storm syndrome. J Autoimmun. 2019;100:62\u201374.","journal-title":"J Autoimmun"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"e124370","DOI":"10.1172\/jci.insight.124370","volume":"4","author":"LK Weaver","year":"2019","unstructured":"Weaver LK, et al. Microbiota-dependent signals are required to sustain TLR-mediated immune responses. JCI Insight. 2019;4:e124370.","journal-title":"JCI Insight"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","volume":"127","author":"R Das","year":"2016","unstructured":"Das R, et al. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood. 2016;127:1666\u201375.","journal-title":"Blood"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/art.33496","volume":"64","author":"R Strippoli","year":"2012","unstructured":"Strippoli R, et al. Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome. Arthritis Rheum. 2012;64:1680\u20138.","journal-title":"Arthritis Rheum"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385\u201395.","journal-title":"N Engl J Med"},{"issue":"6","key":"12_CR28","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/mr\/roab119","volume":"32","author":"J Wu","year":"2021","unstructured":"Wu J, et al. Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis associated refractory macrophage activation syndrome. Mod Rheumatol. 2021;32(6):1114\u201321. https:\/\/doi.org\/10.1093\/mr\/roab119.","journal-title":"Mod Rheumatol"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1073\/pnas.1820704116","volume":"116","author":"A Wang","year":"2019","unstructured":"Wang A, et al. Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice. Proc Natl Acad Sci U S A. 2019;116:2200\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jaci.2014.11.030","volume":"135","author":"B Tesi","year":"2015","unstructured":"Tesi B, et al. Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-gamma receptor deficiency. J Allergy Clin Immunol. 2015;135:1638\u201341.","journal-title":"J Allergy Clin Immunol"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/ped.13064","volume":"58","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management. Pediatr Int. 2016;58:817\u201325.","journal-title":"Pediatr Int"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","volume":"118","author":"MB Jordan","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118:4041\u201352.","journal-title":"Blood"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","volume":"121","author":"CE Terrell","year":"2013","unstructured":"Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood. 2013;121:5184\u201391.","journal-title":"Blood"},{"key":"12_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","volume":"212","author":"MR Jenkins","year":"2015","unstructured":"Jenkins MR, et al. Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212:307\u201317.","journal-title":"J Exp Med"},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","volume":"196","author":"M Zhang","year":"2016","unstructured":"Zhang M, et al. A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis. J Immunol. 2016;196:2492\u2013503.","journal-title":"J Immunol"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/art.38793","volume":"66","author":"KM Kaufman","year":"2014","unstructured":"Kaufman KM, et al. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2014;66:3486\u201395.","journal-title":"Arthritis Rheumatol"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","volume":"104","author":"MB Jordan","year":"2004","unstructured":"Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004;104:735\u201343.","journal-title":"Blood"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","volume":"382","author":"F Locatelli","year":"2020","unstructured":"Locatelli F, et al. Emapalumab in children with primary hemophagocytic lymphohistiocytosis. N Engl J Med. 2020;382:1811\u201322.","journal-title":"N Engl J Med"},{"key":"12_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/blood-2011-06-363994","volume":"119","author":"M Chen","year":"2012","unstructured":"Chen M, Felix K, Wang J. Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood. 2012;119:127\u201336.","journal-title":"Blood"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1600-0609.2006.00730.x","volume":"77","author":"DJ Schaer","year":"2006","unstructured":"Schaer DJ, Schaer CA, Schoedon G, Imhof A, Kurrer MO. Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis. Eur J Haematol. 2006;77:432\u20136.","journal-title":"Eur J Haematol"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.trsl.2015.06.011","volume":"167","author":"SW Ryter","year":"2016","unstructured":"Ryter SW, Choi AM. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res. 2016;167:7\u201334.","journal-title":"Transl Res"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/art.38379","volume":"66","author":"SW Canna","year":"2014","unstructured":"Canna SW, et al. Brief report: alternative activation of laser-captured murine hemophagocytes. Arthritis Rheumatol. 2014;66:1666\u201371.","journal-title":"Arthritis Rheumatol"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.immuni.2013.06.019","volume":"39","author":"H Ohyagi","year":"2013","unstructured":"Ohyagi H, et al. Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses. Immunity. 2013;39:584\u201398.","journal-title":"Immunity"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1089\/ars.2013.5673","volume":"20","author":"TD Hull","year":"2014","unstructured":"Hull TD, Agarwal A, George JF. The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1. Antioxid Redox Signal. 2014;20:1770\u201388.","journal-title":"Antioxid Redox Signal"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/art.41285","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020;72:1059\u201363.","journal-title":"Arthritis Rheumatol"},{"key":"12_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720109","volume":"12","author":"R Knoll","year":"2021","unstructured":"Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and macrophages in COVID-19. Front Immunol. 2021;12:720109.","journal-title":"Front Immunol"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636\u201343.","journal-title":"Nat Med"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463\u20139.","journal-title":"Nature"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam PS, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369:1210\u201320.","journal-title":"Science"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1213\/ANE.0000000000005044","volume":"131","author":"T Spinetti","year":"2020","unstructured":"Spinetti T, et al. Reduced monocytic human leukocyte antigen-DR expression indicates immunosuppression in critically ill COVID-19 patients. Anesth Analg. 2020;131:993\u20139.","journal-title":"Anesth Analg"},{"key":"12_CR51","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41423-020-0483-y","volume":"17","author":"F Wang","year":"2020","unstructured":"Wang F, et al. Systemically comparing host immunity between survived and deceased COVID-19 patients. Cell Mol Immunol. 2020;17:875\u20137.","journal-title":"Cell Mol Immunol"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","volume":"606","author":"C Junqueira","year":"2022","unstructured":"Junqueira C, et al. FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature. 2022;606:576\u201384.","journal-title":"Nature"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","volume":"38","author":"RL Chua","year":"2020","unstructured":"Chua RL, et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38:970\u20139.","journal-title":"Nat Biotechnol"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao M, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26:842\u20134.","journal-title":"Nat Med"},{"key":"12_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03569-1","volume":"595","author":"JC Melms","year":"2021","unstructured":"Melms JC, et al. A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021;595:114\u20139.","journal-title":"Nature"},{"key":"12_CR56","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41422-020-00455-9","volume":"31","author":"E Wauters","year":"2021","unstructured":"Wauters E, et al. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages. Cell Res. 2021;31:272\u201390.","journal-title":"Cell Res"},{"issue":"4","key":"12_CR57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383(4):347\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2021756.","journal-title":"N Engl J Med"},{"issue":"4","key":"12_CR58","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2021680.","journal-title":"N Engl J Med"},{"issue":"11","key":"12_CR59","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1172\/JCI141113","volume":"130","author":"PY Lee","year":"2020","unstructured":"Lee PY, et al. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020;130(11):5942\u201350. https:\/\/doi.org\/10.1172\/JCI141113.","journal-title":"J Clin Invest"},{"key":"12_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana J, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.","journal-title":"BMJ"},{"issue":"10239","key":"12_CR61","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)31103-X.","journal-title":"Lancet"},{"key":"12_CR62","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","volume":"183","author":"CN Gruber","year":"2020","unstructured":"Gruber CN, et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell. 2020;183:982\u2013995 e914.","journal-title":"Cell"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","volume":"183","author":"CR Consiglio","year":"2020","unstructured":"Consiglio CR, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183:968\u2013981 e967.","journal-title":"Cell"},{"key":"12_CR64","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1503\/cmaj.210873","volume":"194","author":"J Merckx","year":"2022","unstructured":"Merckx J, et al. Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study. CMAJ. 2022;194:E513\u201323.","journal-title":"CMAJ"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"e146614","DOI":"10.1172\/JCI146614","volume":"131","author":"RA Porritt","year":"2021","unstructured":"Porritt RA, et al. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J Clin Invest. 2021;131:e146614.","journal-title":"J Clin Invest"},{"key":"12_CR66","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41591-022-01724-3","volume":"28","author":"K Sacco","year":"2022","unstructured":"Sacco K, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. 2022;28:1050\u201362.","journal-title":"Nat Med"},{"key":"12_CR67","first-page":"1072","volume":"2","author":"C de Cevins","year":"2021","unstructured":"de Cevins C, et al. A monocyte\/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis. Med (N Y). 2021;2:1072\u20131092 e1077.","journal-title":"Med (N Y)"},{"key":"12_CR68","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jaci.2017.07.021","volume":"141","author":"G Prencipe","year":"2018","unstructured":"Prencipe G, et al. Neutralization of IFN-gamma reverts clinical and laboratory features in a mouse model of macrophage activation syndrome. J Allergy Clin Immunol. 2018;141:1439\u201349.","journal-title":"J Allergy Clin Immunol"},{"key":"12_CR69","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/art.38359","volume":"66","author":"A Avau","year":"2014","unstructured":"Avau A, et al. Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund's complete adjuvant: regulation by interferon-gamma. Arthritis Rheumatol. 2014;66:1340\u201351.","journal-title":"Arthritis Rheumatol"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2015-07-659813","volume":"127","author":"JE Rood","year":"2016","unstructured":"Rood JE, et al. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood. 2016;127:426\u201335.","journal-title":"Blood"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokine Storm Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-59815-9_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:03:38Z","timestamp":1723154618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-59815-9_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031598142","9783031598159"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-59815-9_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"9 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}